India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), is building an end-to-end digital drug regulatory platform that the Drug Controller General of India (DCGI) expects to launch in…
India's drug regulator is signalling a major shift in how it oversees the pharmaceutical industry — moving from a uniform, checklist-based inspection model toward a smarter, risk-based approach that could…
When you are buying generic medicines from India, one of the most important quality signals you can check is the WHO-GMP (World Health Organization Good Manufacturing Practice) certificate. But what…
The Indian pharmaceutical sector delivered a strong trio of developments in September 2026 — the iPHEX 2026 expo generated an estimated US$4.5–5 billion in potential business discussions, the domestic market…